Lucas C. Mendez

1.3k total citations
83 papers, 782 citations indexed

About

Lucas C. Mendez is a scholar working on Pulmonary and Respiratory Medicine, Radiation and Surgery. According to data from OpenAlex, Lucas C. Mendez has authored 83 papers receiving a total of 782 indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Pulmonary and Respiratory Medicine, 29 papers in Radiation and 27 papers in Surgery. Recurrent topics in Lucas C. Mendez's work include Prostate Cancer Diagnosis and Treatment (37 papers), Advanced Radiotherapy Techniques (29 papers) and Prostate Cancer Treatment and Research (29 papers). Lucas C. Mendez is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (37 papers), Advanced Radiotherapy Techniques (29 papers) and Prostate Cancer Treatment and Research (29 papers). Lucas C. Mendez collaborates with scholars based in Canada, Brazil and United States. Lucas C. Mendez's co-authors include Gerard Morton, David D’Souza, Eric Leung, Fábio Ynoe de Moraes, Ananth Ravi, Lisa Barbera, Andrew Loblaw, Hans T. Chung, Chia‐Lin Tseng and Patrick Cheung and has published in prestigious journals such as Journal of Clinical Oncology, Scientific Reports and The FASEB Journal.

In The Last Decade

Lucas C. Mendez

79 papers receiving 778 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lucas C. Mendez Canada 17 350 261 190 177 168 83 782
Brandon M. Barney United States 14 339 1.0× 250 1.0× 187 1.0× 182 1.0× 371 2.2× 25 899
Martin T. King United States 14 477 1.4× 193 0.7× 205 1.1× 81 0.5× 102 0.6× 109 781
Amelia Barcellini Italy 15 240 0.7× 176 0.7× 153 0.8× 103 0.6× 194 1.2× 97 706
Lilie L. Lin United States 17 247 0.7× 213 0.8× 156 0.8× 213 1.2× 172 1.0× 34 673
Ben Vanneste Netherlands 19 495 1.4× 328 1.3× 280 1.5× 87 0.5× 253 1.5× 73 923
Susan Lalondrelle United Kingdom 17 234 0.7× 259 1.0× 278 1.5× 111 0.6× 285 1.7× 57 853
P. Franzone Italy 16 448 1.3× 408 1.6× 263 1.4× 145 0.8× 172 1.0× 53 840
John Einck United States 21 403 1.2× 218 0.8× 257 1.4× 222 1.3× 330 2.0× 69 1.1k
Jonathan Smith United Kingdom 16 276 0.8× 194 0.7× 200 1.1× 40 0.2× 123 0.7× 33 709
I. Fumagalli France 15 167 0.5× 154 0.6× 143 0.8× 170 1.0× 162 1.0× 40 557

Countries citing papers authored by Lucas C. Mendez

Since Specialization
Citations

This map shows the geographic impact of Lucas C. Mendez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lucas C. Mendez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lucas C. Mendez more than expected).

Fields of papers citing papers by Lucas C. Mendez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lucas C. Mendez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lucas C. Mendez. The network helps show where Lucas C. Mendez may publish in the future.

Co-authorship network of co-authors of Lucas C. Mendez

This figure shows the co-authorship network connecting the top 25 collaborators of Lucas C. Mendez. A scholar is included among the top collaborators of Lucas C. Mendez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lucas C. Mendez. Lucas C. Mendez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Huang, Yueting, et al.. (2024). Efficacy and safety of PARP inhibitors in the treatment of prostatic cancer: a systematic review and network meta-analysis. Chinese Clinical Oncology. 13(4). 64–64. 2 indexed citations
4.
Raziee, Hamid, et al.. (2024). Hypofractionated Radiotherapy in Gynecologic Malignancies—A Peek into the Upcoming Evidence. Cancers. 16(2). 362–362. 6 indexed citations
5.
Harding, Thomas H., Lucas C. Mendez, David D’Souza, et al.. (2023). Deep learning‐based ultrasound auto‐segmentation of the prostate with brachytherapy implanted needles. Medical Physics. 51(4). 2665–2677. 4 indexed citations
6.
Mendez, Lucas C., Juanita Crook, Kevin Martell, et al.. (2023). Is Ultrahypofractionated Whole Pelvis Radiation Therapy (WPRT) as Well Tolerated as Conventionally Fractionated WPRT in Patients With Prostate Cancer? Early Results From the HOPE Trial. International Journal of Radiation Oncology*Biology*Physics. 119(3). 803–812. 4 indexed citations
7.
Wang, Hanzhi, Lucas C. Mendez, Gerard Morton, et al.. (2020). Immune cell profiling in Gleason 9 prostate cancer patients treated with brachytherapy versus external beam radiotherapy: An exploratory study. Radiotherapy and Oncology. 155. 80–85. 7 indexed citations
8.
Han, Kathy, Lucas C. Mendez, David D’Souza, et al.. (2020). Management of gynecologic cancer: Choosing radiotherapy wisely by 3 Southern Ontario academic centers during the COVID-19 pandemic. Radiotherapy and Oncology. 151. 15–16. 4 indexed citations
9.
Lang, Pencilla, Neil Mundi, S. Danielle MacNeil, et al.. (2020). Modern treatment outcomes for early T-stage oropharyngeal cancer treated with intensity-modulated radiation therapy at a tertiary care institution. Radiation Oncology. 15(1). 261–261. 12 indexed citations
10.
Mendez, Lucas C., Vikram Velker, Eric Leung, et al.. (2020). 3D image-guided interstitial brachytherapy for primary vaginal cancer: A multi-institutional experience. Gynecologic Oncology. 160(1). 134–139. 6 indexed citations
11.
Raziee, Hamid, David D’Souza, Vikram Velker, et al.. (2019). Salvage Re-irradiation With Single-modality Interstitial Brachytherapy for the Treatment of Recurrent Gynaecological Tumours in the Pelvis: A Multi-institutional Study. Clinical Oncology. 32(1). 43–51. 16 indexed citations
13.
Mendez, Lucas C., et al.. (2019). Lives and Economic Loss in Brazil due to Lack of Radiotherapy Access in Cervical Cancer: A Cost-Effectiveness Analysis. Clinical Oncology. 31(9). e143–e148. 6 indexed citations
14.
Mendez, Lucas C., Alexander V. Louie, Matt Wronski, et al.. (2018). Evaluation of a new predictor of heart and left anterior descending artery dose in patients treated with adjuvant radiotherapy to the left breast. Radiation Oncology. 13(1). 124–124. 8 indexed citations
15.
Mendez, Lucas C., Srinivas Raman, Bo Wan, et al.. (2017). Quality of life in responders after palliative radiation therapy for painful bone metastases using EORTC QLQ-C30 and EORTC QLQ-BM22: results of a Brazilian cohort. Annals of Palliative Medicine. 6(S1). S65–S70. 10 indexed citations
16.
Moraes, Fábio Ynoe de, Lucas C. Mendez, Neil K. Taunk, et al.. (2017). Funding source, conflict of interest and positive conclusions in neuro-oncology clinical trials. Journal of Neuro-Oncology. 136(3). 585–593. 5 indexed citations
17.
Chiu, Nicholas, Leonard Chiu, Marko M. Popovic, et al.. (2016). Latest advances in the management of radiation-induced pain flare, nausea and vomiting.. PubMed. 5(1). 50–7. 9 indexed citations
18.
Chiu, Nicholas, Leonard Chiu, Marko M. Popovic, et al.. (2015). Re-irradiation for painful bone metastases: evidence-based approach.. PubMed. 4(4). 214–9. 3 indexed citations
19.
Mendez, Lucas C., et al.. (2012). Leishmania amazonensis fails to induce the release of reactive oxygen intermediates by CBA macrophages. Parasite Immunology. 34(10). 492–498. 23 indexed citations
20.
Macambira, Simone Garcia, Juliana Fraga Vasconcelos, Wilfried Klein, et al.. (2009). Granulocyte colony‐stimulating factor treatment in chronic Chagas disease: preservation and improvement of cardiac structure and function. The FASEB Journal. 23(11). 3843–3850. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026